TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

26.60$ -3.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Zymeworks Inc. (ZYME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 4.6 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZYME
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
17 17 10 19 16 31 27 49 28 2.5 2.4 4.6 37
33 25 33 2.5 2.7 -27 3.3 3.2 1.7 2.8
17 17 10 19 16 31 27 49 28 0.8 -0.4 4.6 33
33 26 32 29 36 37 36 34 36 31 2,408 32 2,507
17 15 1.2 16 14 16 17 15 14 14 15,069 19 15,116
50 40 48 62 50 53 53 49 50 45 47 47 188
-33 -23 -38 -43 -34 -22 -26 -0.7 -22 -44 -47 -42 -156
7.2 0.0 0.0 2.1 6,595
-28 -19 -32 -38 -30 -18 -22 2.1 -18 -41 -46 -45 -151
1.1 -4.7 0.1 0.1 0.2 5.7 0.5 -0.2 1.3 -0.3 -2.2 -0.3 -1.4
-29 -14 -32 -38 -30 -24 -23 2.3 -20 -41 -44 -45 -150
-27 -20 -21 -23 -32 -19 -22 2.6 -16 -40 -41 -43 -140

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?